← Back to Clinical Trials
Recruiting NCT06831604

NCT06831604 Superficial Cervical Plexus Block With Either Clavipectoral Fascial Plane Block or Interscalene Brachial Block for Clavicle Surgeries Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06831604
Status Recruiting
Phase
Sponsor Tanta University
Condition Ultrasound
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-02-20
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Superficial Cervical Plexus Block (SCPB) and Clavipectoral Fascial Plane Block (CPB)Superficial Cervical Plexus Block (SCPB) and Interscalene Brachial Block (ISBP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-02-20 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate and compare the efficacy and safety of ultrasound guided superficial cervical plexus block (SCPB) with either clavipectoral fascial plane block (CPB) or interscalene brachial plexus block (ISBP) as an anesthetic technique for clavicle surgeries.

Eligibility Criteria

Inclusion Criteria: * Aged 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I, II. * Patients with unilateral clavicular fractures undergo elective internal fixation of clavicle fractures. Exclusion Criteria: * Coagulopathy. * Patients with infection at block site. * Allergy to local anesthetics. * Patient with morbid obesity (body mass index \>35 kg/m2). * Pre-existing neurological disease. * Difficult communication.

Contact & Investigator

Central Contact

Ahmed M Aboeldahab, Master

✉ ahmed.aboeldahab1422@gmail.com

📞 00201069784512

Frequently Asked Questions

Who can join the NCT06831604 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06831604 currently recruiting?

Yes, NCT06831604 is actively recruiting participants. Contact the research team at ahmed.aboeldahab1422@gmail.com for enrollment information.

Where is the NCT06831604 trial being conducted?

This trial is being conducted at Tanta, Egypt.

Who is sponsoring the NCT06831604 clinical trial?

NCT06831604 is sponsored by Tanta University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology